Q2 2021 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript
Good day and welcome to the Sartorius and Sartorius Stedim Biotech conference call on the first half of 2021 results. Today's conference is being recorded.
At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead, sir.
Thank you very much and good day, everybody, from Sartorius. I'm here together with Rainer Lehmann, our CFO, and we would like to talk about the half year's results of Sartorius and Sartorius Stedim Biotech as just announced.
As always, I would like to kick it off with mentioning a couple of highlights that we see being the most important developments during the first 6 months of this year, then Rainer will talk -- take over and talk about the financial results in more detail and then I will continue with the outlook for the full year and the SSB results.
So we have been achieving 60% top line growth during the first 6 months. Of this, 22 percentage points are corona-related. We will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
